Unusual 11 Mid-Day Movers 03/06: (EBTX) (HNR) (DUSA) Higher; (ONTY) (ZLTQ) (DATE) Lower
Tweet
Share
E-mail
Get Alerts ONTY Hot Sheet
Join SI Premium – FREE
Oncothyreon, Inc. (Nasdaq: ONTY) 39.8% LOWER; reported Q4 EPS of ($0.27), 12 cents worse than the analyst estimate of ($0.15). Expenses in 2012 are expected to be higher when compared to 2011, primarily as a result of the more advanced clinical development of PX-866 and the Phase 1 clinical trial of ONT-10. Oncothyreon currently expects cash used in operations in 2012 to be between approximately $30.0 and approximately $33.0 million. As a result, Oncothyreon estimates that its existing cash, cash-equivalents and investments will be sufficient to fund operations for at least the next 12 months.
Encore Bancshares, Inc. (Nasdaq: EBTX) 35.5% HIGHER; Cadence Bancorp entered into a definitive agreement to purchase Encore Bancshares in an all-cash transaction. Cadence will pay $20.62 per share, or about $250 million in total.
ZELTIQ Aesthetics (Nasdaq: ZLTQ) 30.3% LOWER; reported Q4 EPS of ($0.22), 13 cents worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $18.8 million versus the consensus estimate of $22 million. Sees FY2012 revenue of $90-$94 million, versus the consensus of $113.9 million.
Harvest Natural Resources, Inc. (NYSE: HNR) 28.4% HIGHER; revising 2011 financial statements for errors: the cumulative net adjustment increases net income by about $3 million. The company said it is currently in talks on its Petrodelta unit. The stock was upgraded at Pritchard earlier.
DUSA Pharmaceuticals, Inc. (Nasdaq: DUSA) 23.2% HIGHER; reported Q4 EPS of $0.16, $0.03 better than the analyst estimate of $0.13. Revenue for the quarter came in at $15.3 million versus the consensus estimate of $13.84 million.
Xoma (Nasdaq: XOMA) 21.5% HIGHER; priced a 29.7 million common offering at $1.32 each.
Jiayuan.com (Nasdaq: DATE) 16.6% LOWER; reported Q4 non-GAAP EPS of $0.01, 5 cents worse than the analyst estimate of $0.06. Revenue for the quarter came in at $14.1 million versus the consensus estimate of $14.39 million. Jiayuan currently expects to generate net revenues in the range of RMB90 million to RMB92 million for the first quarter of 2012.
Standard Motor Products (NYSE: SMP) 16.5% LOWER; reported Q4 EPS of $0.17, $0.03 better than the analyst estimate of $0.14. Revenue for the quarter came in at $174.2 million versus the consensus estimate of $182.31 million. Sees first quarter 2012 sales flat to slightly below 2011 first quarter results.
Keryx Biopharma (Nasdaq: KERX) 16.2% LOWER; biotech stocks Keryx and Æterna Zentaris are both lower Tuesday as there is now questions about analysis of the recent Seeking Alpha article which said FDA approval is "practically a done deal". Click here to see the full report.
Shuffle Master, Inc. (Nasdaq: SHFL) 12.8% HIGHER; reported Q1 EPS of $0.09, which was 2 cents worse than the analyst estimate of $0.11. Revenue for the quarter came in at $56.1 million versus the consensus estimate of $51.11 million. The company entered into a definitive agreement to acquire Ongame Network Ltd., from bwin.party Services (Austria) GmbH.
Medidata Solutions, Inc. (NASDAQ: MDSO) 11.1% HIGHER; reported Q4 EPS of $0.37, in-line with the analyst estimate of $0.37. Revenue for the quarter came in at $47.2 million versus the consensus estimate of $47.14 million. Sees FY2012 revenue of $210-$215 million, versus the consensus of $205.10 million. Sees Q1 2012 revenue of $48.5-$49.5 million, versus the consensus of $47.90 million.
To get this report daily visit http://www.streetinsider.com/entities/Unusual+11+Mid-Day+Movers.
Encore Bancshares, Inc. (Nasdaq: EBTX) 35.5% HIGHER; Cadence Bancorp entered into a definitive agreement to purchase Encore Bancshares in an all-cash transaction. Cadence will pay $20.62 per share, or about $250 million in total.
ZELTIQ Aesthetics (Nasdaq: ZLTQ) 30.3% LOWER; reported Q4 EPS of ($0.22), 13 cents worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $18.8 million versus the consensus estimate of $22 million. Sees FY2012 revenue of $90-$94 million, versus the consensus of $113.9 million.
Harvest Natural Resources, Inc. (NYSE: HNR) 28.4% HIGHER; revising 2011 financial statements for errors: the cumulative net adjustment increases net income by about $3 million. The company said it is currently in talks on its Petrodelta unit. The stock was upgraded at Pritchard earlier.
DUSA Pharmaceuticals, Inc. (Nasdaq: DUSA) 23.2% HIGHER; reported Q4 EPS of $0.16, $0.03 better than the analyst estimate of $0.13. Revenue for the quarter came in at $15.3 million versus the consensus estimate of $13.84 million.
Xoma (Nasdaq: XOMA) 21.5% HIGHER; priced a 29.7 million common offering at $1.32 each.
Jiayuan.com (Nasdaq: DATE) 16.6% LOWER; reported Q4 non-GAAP EPS of $0.01, 5 cents worse than the analyst estimate of $0.06. Revenue for the quarter came in at $14.1 million versus the consensus estimate of $14.39 million. Jiayuan currently expects to generate net revenues in the range of RMB90 million to RMB92 million for the first quarter of 2012.
Standard Motor Products (NYSE: SMP) 16.5% LOWER; reported Q4 EPS of $0.17, $0.03 better than the analyst estimate of $0.14. Revenue for the quarter came in at $174.2 million versus the consensus estimate of $182.31 million. Sees first quarter 2012 sales flat to slightly below 2011 first quarter results.
Keryx Biopharma (Nasdaq: KERX) 16.2% LOWER; biotech stocks Keryx and Æterna Zentaris are both lower Tuesday as there is now questions about analysis of the recent Seeking Alpha article which said FDA approval is "practically a done deal". Click here to see the full report.
Shuffle Master, Inc. (Nasdaq: SHFL) 12.8% HIGHER; reported Q1 EPS of $0.09, which was 2 cents worse than the analyst estimate of $0.11. Revenue for the quarter came in at $56.1 million versus the consensus estimate of $51.11 million. The company entered into a definitive agreement to acquire Ongame Network Ltd., from bwin.party Services (Austria) GmbH.
Medidata Solutions, Inc. (NASDAQ: MDSO) 11.1% HIGHER; reported Q4 EPS of $0.37, in-line with the analyst estimate of $0.37. Revenue for the quarter came in at $47.2 million versus the consensus estimate of $47.14 million. Sees FY2012 revenue of $210-$215 million, versus the consensus of $205.10 million. Sees Q1 2012 revenue of $48.5-$49.5 million, versus the consensus of $47.90 million.
To get this report daily visit http://www.streetinsider.com/entities/Unusual+11+Mid-Day+Movers.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- After-Hours Movers: AMAT, DLO, GLOB, YSS, ETON
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
Create E-mail Alert Related Categories
Special ReportsRelated Entities
Unusual 11 Mid-Day MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
